Home The Active Ingredient Matrix Ganoderma lucidum (Ganoderic Acid A)

Formulation Intelligence

Ganoderma lucidum (Ganoderic Acid A)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ganoderma lucidum (Ganoderic Acid A).

Ganoderma lucidum functions as a potent immunomodulator and adaptogen, primarily through the activation of toll-like receptors and the modulation of NF-κB signaling pathways to enhance cytokine production and cellular antioxidant defenses.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

112521

Molecular Weight

375.2 g/mol

XLogP3 (Lipophilicity)

5

IUPAC Name

[4-(3-chloro-3-oxoprop-1-enyl)phenyl]-[4-(3-chloro-3-oxoprop-1-enyl)phenyl]imino-oxidoazanium

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Vitamin C for [enhancing the intestinal absorption of high-molecular-weight polysaccharides]
  • Cordyceps sinensis for [synergistic modulation of the HPA axis and ATP production]

Biological Formulation Enhancers

  • Piperine for [inhibiting glucuronidation to increase the systemic bioavailability of triterpenoids]
  • Lecithin for [improving the micellar solubilization of lipophilic ganoderic acids]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ganoderma lucidum (Ganoderic Acid A) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Ganoderma extracts requires moisture-resistant HPMC capsules and desiccants to prevent clumping and degradation of bioactive triterpenes.

🍬 Gummy & Pectin Formats

High concentrations of bitter triterpenoids present significant organoleptic challenges, requiring advanced masking agents to prevent a lingering metallic aftertaste in pectin-based matrices.

🔬 Thin-Film Oral Strips

The high therapeutic dosage required for effective polysaccharide delivery exceeds the typical 50mg payload capacity of thin-film polymers, necessitating highly concentrated extract ratios.

For Brand Founders

Formulate with Ganoderma lucidum (Ganoderic Acid A)

Ready to launch a product featuring Ganoderma lucidum (Ganoderic Acid A)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Ganoderma lucidum (Ganoderic Acid A) Bioavailability

Need absolute proof that your Ganoderma lucidum (Ganoderic Acid A) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Ganoderma lucidum (Ganoderic Acid A) Degradation Testing

Is your Ganoderma lucidum (Ganoderic Acid A) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation